The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective studyPei Ni Ding, Tara L. Roberts, Therese M. Becker et al.|Lung Cancer|2019Cited by 41
Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancerMarra Aghajani, Navin Niles, Tao Yang et al.|Endocrine Connections|2019Cited by 28
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N. Ding, Victoria Bray, Tara L. Roberts et al.|Translational Lung Cancer Research|2021Cited by 11
Longitudinal analysis of circulating biomarkers to monitor advanced EGFR mutated (EGFR+) non-small cell lung cancer (NSCLC)Pei Ni Ding, Tara L. Roberts, Therese M. Becker et al.|Annals of Oncology|2018Cited by 0
Abstract A16: Suppressor of morphogenesis in genitalia 1 (SMG1) is a novel negative regulator of mammalian target of rapamycin complex 2 (mTORC2)Alexander C. James, Tara L. Roberts, Patricia Rebeiro et al.|Molecular Cancer Research|2020Cited by 0